Randomized Double Blind Controlled Trial on Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus

Trial Profile

Randomized Double Blind Controlled Trial on Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2017

At a glance

  • Drugs Sulodexide (Primary)
  • Indications Thrombosis; Tinnitus
  • Focus Therapeutic Use
  • Acronyms SECIST
  • Most Recent Events

    • 13 Sep 2017 Status changed from active, no longer recruiting to completed.
    • 22 Jan 2017 Planned End Date changed from 1 Mar 2017 to 1 Aug 2017.
    • 22 Jan 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top